IRADIMED CORP
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| · · · · · · · | |||||
|---|---|---|---|---|---|
| · · Year Ended | |||||
| · · · December 31, | |||||
| · · · 2024 · 2023 | |||||
| Operating activities: · · · | |||||
| Net income | | | $19,234,026 | | $17,192,776 |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | ||
| Allowance for credit losses | | | (94,535) | | 208,337 |
| Provision for excess and obsolete inventory | | | 87,641 | | 181,443 |
| Depreciation & amortization | | | 817,656 | | 765,180 |
| Loss on disposal of property and equipment | | | 3,871 | | 12,537 |
| Stock-based compensation | | | 2,524,536 | | 2,186,909 |
| Deferred income taxes, net | | | (697,652) | | (1,171,908) |
| Changes in operating assets and liabilities: | | | | | |
| Accounts receivable | | | 1,762,075 | | 841,911 |
| Inventory | | | 3,126,046 | | (7,468,170) |
| Prepaid expenses and other current assets | | | (320,233) | | (562,487) |
| Other assets | | | (17,463) | | 467,223 |
| Accounts payable | | | (861,618) | | (216,436) |
| Accrued payroll and benefits | | | 996,653 | | (96,787) |
| Other accrued taxes | | | 59,757 | | (18,678) |
| Warranty reserve | | | 806 | | 23,433 |
| Deferred revenue | | | (111,052) | | 615,636 |
| Other current liabilities | | | (100,000) | | 250,000 |
| Prepaid income taxes | | | (786,051) | | 254,093 |
| Net cash provided by operating activities | | | 25,624,463 | | 13,465,012 |
| Investing activities: | | | | ||
| Purchases of property and equipment | | | (8,005,033) | | (7,440,510) |
| Capitalized intangible assets | | | (811,753) | | (566,657) |
| Net cash used in investing activities | | | (8,816,786) | | (8,007,167) |
| Financing activities: | | | | ||
| Dividends paid | | | (13,677,426) | | (13,222,907) |
| Proceeds from exercises of stock options | | | 29,618 | | 176,744 |
| Taxes paid related to the net share settlement of equity awards | | | (688,160) | | (610,348) |
| Net cash used in financing activities | | | (14,335,968) | | (13,656,511) |
| Net increase (decrease) in cash and cash equivalents | | | 2,471,709 | | (8,198,666) |
| Cash and cash equivalents, beginning of period | | | 49,762,198 | | 57,960,864 |
| Cash and cash equivalents, end of period | | | $52,233,907 | | $49,762,198 |
| Supplemental disclosure of cash flow information: | | | | ||
| Dividends declared not yet paid | | | $— | | $7,975,997 |
| Cash paid for income taxes | | | $6,511,827 | | $5,351,708 |
| ROU asset recognized in exchange for new lease obligation | | | $— | | $227,982 |
| ROU asset and liability adjustment | | | $1,486,093 | | $— |
| Operating and short-term lease payments recorded within cash flow provided by operating activities | | | $816,932 | | $675,190 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.